🇺🇸 FDA
Pipeline program

ASCs (Cx401, company code)

Cx401/FATT1

Phase 3 small_molecule completed

Quick answer

ASCs (Cx401, company code) for Anal Fistula is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Anal Fistula
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials